Create
Log in
Enquire now
Senti Biosciences
Senti Biosciences is a synthetic biology company.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Organization
Company
AngelList URL
angel.co/senti-biosciences-1
B2X
B2B
Business Model
Commerce
CEO
Timothy Lu
0
CFO
Deborah Knobelman
0
CIK Number
1,732,195
Legal Name
Senti Biosciences, Inc.
Company Operating Status
Active
COO
Curt Herberts
0
Country
United States
0
Crunchbase URL
crunchbase.com/organiz...sciences
CTO
Philip Lee
0
Date Incorporated
2016
DUNS Number
080288233
Email Address
investors@sentibio.com
0
Founded Date
2016
Founder
Jim Collins
Timothy Lu
0
Philip Lee
Wilson Wong
Full Address
2 Corporate Dr FL 1 South San Francisco, CA, 94080-7047 United States
0
Industry
Immunotherapy
Therapeutics
Cancer immunotherapy
Oncology
Cell therapy
Therapy
Biomedical engineering
Biopharmaceutical
Electronic health record
Genetics
•••
Investors
Goodman Capital
Intel Capital
Nest.Bio Ventures
Mirae Asset Capital
Ridgeback Capital
Amgen Ventures
Leaps by Bayer
Intel Capital Diversity Fund
Allen & Company
Pear (venture capital)
•••
Latest Funding Round Date
January 2021
Latest Funding Type
Series B
Legal classification
Corporation
LinkedIn URL
@company/senti-biosciences
Location
South San Francisco, California
0
United States
San Francisco
Number of Employees
101
0
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles...182414-08
Total Funding Amount (USD)
158,000,000
Twitter URL
@SentiBio
Official Website
sentibio.com
Wellfound ID
senti-biosciences-1
Find more companies like Senti Biosciences
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE